Background In recent years, there has been rapid growth in pharmaceutical spending in
China. In addition, the country faces many challenges with regards to the quality, pricing and …

Objective: This systematic review aimed to discuss the effects of a zero-markup policy for
essential drugs (ZPED) on healthcare costs and utilization in China in the years 2015–2021 …

Since economic liberalization in the late 1970s, China's health care providers have grown
heavily reliant on revenue from drugs, which they both prescribe and sell. To curb abuse …

China has a complex pharmaceutical system that is currently undergoing significant reforms.
This book provides a comprehensive overview of China's pharmaceutical system and covers …

Background Healthcare system reform of Sanming city has become a leading healthcare
reform model in China. It has developed a rigorous pharmaceutical reform consisted of the …

Objective With a quasi-experimental design, this study aims to assess whether the Zero-
markup Policy for Essential Drugs (ZPED) reduces the medical expense for patients at …

To implement state policies of zero-markup drug policy and medical service fee adjustment
for public hospitals, this study constructed game models of the pharmaceutical supply chain …

The rapid diffusion of medical technologies is widely recognized as a key driver of
healthcare cost escalation. The excessive duplication of technologies gives rise to the so …

The zero‐markup drug policy is an important component of the new round of Chinese health
care reform that began in 2009 to promote the separation between medical and …

Objectives: The aim of this study was to determine the impact of the Zero Markup drug (ZMD)
policy on hospitalization expenses for inpatients in tertiary Chinese hospitals. Methods …